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The calcium ionophore A23187 acted synergistically with phorbol dibutyrate (PDBu) to stimulate human 
neutrophil superoxide production. A23187 shortened the lag period and markedly increased the initial rate 
of neutrophil superoxide production induced by suboptimal concentrations of PDBu. 1 PM A23 187 reduced 
the EC& value for superoxide release from 56 to 8 nM PDBu. This effect of A23187 was correlated with 
enhanced binding of [3H]PDBu to its receptor and a reduction in the dissociation constant (&) from 27 
to 10 nM, without altering the apparent total number of phorbol dibutyrate receptors. These actions of 
A23 187 were abolished in the presence of EGTA or TMB-8, confirming a dependence on Ca*+. 
Ca2+; Ionophore A23187; Phorbol ester; Protein kinase C; Neutrophil 
1. INTRODUCTION 
Tumour-promoting phorbol esters are potent 
stimulants of neutrophil (PMN) superoxide anion 
production [ 11. The major cellular receptor for 
phorbol esters is now known to be the 
phospholipid/Ca2+-dependent protein kinase (pro- 
tein kinase C) (PKC) [2]; recent evidence suggests 
that phorbol ester binding to PKC is dependent on 
phospholipid [2] and that translocation and 
binding of cytosolic PKC to the plasma membrane 
may therefore be an important step in activation of 
PKC by phorbol ester or diacylglycerol [3]. Recent 
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studies have shown that the calcium ionophore 
A23 187 acts synergistically with phorbol esters to 
elicit a variety of physiological cell responses in- 
cluding guinea pig PMN superoxide production 
[4]. One suggested mechanism for this synergism is 
that the rise in cytosol Ca2+ produced by A23187 
promotes translocation and binding of PKC to the 
cell membrane, thereby increasing availability of 
phospholipid cofactor and thus the affinity of 
binding of PKC for phorbol ester [3,5]. 
In the experiments described here we have in- 
vestigated this hypothesis further by comparing the 
effect of calcium ionophore A23187 on PDBu- 
induced PMN superoxide anion production with 
its effect on the binding of PDBu in human PMN. 
2. MATERIALS AND METHODS 
All reagents were obtained from Sigma except 
for [3H]PDBu (12.5 Ci/mmol) which was obtained 
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from New England Nuclear. Human PMN were 
prepared from venous blood by dextran sedimen- 
tation followed by fractionation on a Percoll gra- 
dient as described [6]. PMN were washed twice and 
resuspended in RPM1 1640 (Flow Labs) + 10% 
fetal calf serum (at lo6 or 5 x lo6 PMN/ml for 
superoxide or PDBu-binding studies, respectively). 
Unless otherwise stated PMN were preincubated 
for 10 min at 37°C with A23187 or methanol sol- 
vent (0.2070, v/v, final) prior to incubation for 
20 min with PDBu or [3H]PDBu in DMSO 
(0.05V0, v/v, final). Final concentrations of 
methanol or DMSO did not affect the performance 
of either assay (not shown). Assay of [3H]PDBu 
binding (in triplicate) was performed as in [7]. 
Non-specific binding was assayed in the presence 
of a 50-fold excess of unlabelled phorbol ester. 
Superoxide production was measured by 
monitoring superoxide dismutase-inhibitable fer- 
ricytochrome c reduction at 550 nm. For kinetic 
experiments ferricytochrome c reduction was 
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Fig.1. Effect of A23187 on PDBu-stimulated superoxide 
production. PMN were treated with 1 PM A23187 or an 
equivalent volume of methanol for 10 min. then PDBu 
for 20 min. In the presence of A23 187 the dose response 
to PDBu was shifted to the left. A23187 + PDBu (0); 
PDBu alone (H). Data represent one typical result from 
three experiments. SE did not exceed 0.8 nmol/106 
PMN. 
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Fig.2. Effect of A23187 on kinetics of PDBu-stimulated 
superoxide production. The initial rate of PMN 
superoxide release was increased and the lag time for 
response to 50 nM PDBu (A) was shortened by 10 min 
pretreatment with 0.1 ,uM (B) or 1 ,uM (C) A23187. 1 pM 
A23187 alone (D) stimulated only minimal superoxide 
release. 
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Fig.3. Dose dependence of the synergistic effect of 
A23 187 on PDBu-stimulated superoxide production. 
10 nM PDBu + A23187 (0); A23187 alone (m). Data 
represent one typical result from five experiments. 
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Table 1 
Synergistic action of A23187 on superoxide release and PDBu binding 
(a) Superoxide release 
(nmol/106 PMN per 
20 min) 
(b) 13H]PDBu binding 
(olo of control) 
+A23187 -A23187 +A23187 -A23187 
(1 PM) (1 /rM) 
PDBu 12.8 f 2.4 1.3 f 0.6 173 f 13 100 
PDBu + EGTA 0.3 f 0.1 0.4 f 0.2 114 f 14 110 f 16 
PDBu + TMB-8 0.9 f 0.3 0.2 f 0.1 111 f 11 113 + 24 
A23187 1.9 j, 0.7 0 
Effect of 2 mM EGTA or 200 /cM TMB-8 on the synergistic action of 1 AM 
A23 187 on mean ( f SE) (a) superoxide release elicited by 10 nM PDBu (n = 
5); (b) binding of 10 nM [3H]PDBu (n = 3) 
February 1987 
monitored continuously at 37°C [8] in a spec- 
trophotometer (LKB) linked to an Apple computer 
i’u’ltraspec reaction rate progr~mej. ached iime 
point measurements of superoxide release ex- 
periments were conducted in duplicate as described 
in 191. 
3. RESULTS AND DISCUSSION 
3.1. Effect of A23187 on superoxide production 
After pretreatment of PMN for 10 min with 
A23187 (1 PM), the dose response for PDBu- 
stimulated PMN superoxide production was 
shifted to the left (fig. 1). The mean ( f SE) concen- 
tration of PDBu which produced 50% of the max- 
imal superoxide response (BC50) was reduced from 
56 f 8 to 8 f 2 nM (n = 3) in the presence of 1 pM 
A23187. At high concentrations of PDBu 
(> 100 nM) A23187 had no synergistic effect 
(fig.1). As reported in [4] the enhancing effect of 
A23187 was due both to a shortening of the lag 
time for response to PDBu and to an increase in 
the initial rate of superoxide release (fig.2). 
A23 187 (1 PM) alone caused only minimal stimula- 
tion of superoxide production (fig.2). 
The synergistic action of A23 187 on the superox- 
ide response licited by a ‘threshold’ concentration 
of PDBu (10 nM) was dose-dependent (fig.3) with 
a mean (f SE) ECSO of 0.18 f 0.07 PM A23187 (n 
= 5). In the presence of EGTA (2 mM) or TMB-8 
(200 /IM) the synergistic effect of A23 187 was in- 
244 
hibited, thus confirming the dependence on Ca’+ 
(table 1). The response to PDBu in the absence of 
. a_..-._ 
~3 1u I was also partiaiiy inhibited by EGTA or 
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Fig.4. Effect of A23187 on the kinetics of binding of 
[3H]PDBu to PMN. 10 min pretreatment with 1 ,uM 
A23 187 increased the extent and rate of PDBu binding 
but did not alter the overall shape of the kinetic curve. 
(0) 10 nM PDBu alone; (m) 10 nM PDBu + 1 PM 
A23187 (SE did not exceed 2 fmol). 
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the intracellular calcium antagonist TMB-8 [lo], cell line [ 111, and may reflect proteolytic cleavage 
emphasizing the importance of Ca2+ in the cellular of PKC and loss of binding sites following activa- 
response to PDBu alone. tion of PKC [12,13]. 
3.2. Effect of A23187 on PDBu binding 
To determine whether the synergistic effect of 
A23187 correlated with increased phorbol ester 
binding, the action of A23187 on [3H]PDBu 
binding to PMN was examined. The time course of 
binding of 10 nM t3H]PDBu to PMN was followed 
over 60 min. After an initial phase of rapid 
binding, which lasted lo-20 min, there was a slow 
decline in PDBu binding. Pretreatment of PMN 
for 10 min with A23 187 (1 PM) increased the in- 
itial rate of PDBu binding, but did not alter the 
overall shape of the kinetic curve (fig.4). Similar 
binding kinetics have been reported for the HL60 
Pretreatment of PMN with A23 187 (1 PM) also 
increased the affinity of binding of phorbol ester 
receptors for PDBu from a single class of low af- 
finity (& 27 I’M) to a single class of high affinity 
(& 10 nM), with no apparent alteration of total 
receptor numbers (fig.5). Thus, as previously 
reported for other cell types (3,141, A23187 ap- 
pears to convert low-affinity PDBu receptors to 
high affinity. These data are consistent with the 
hypothesis that a rise in cytosol Ca2’ converts low- 
affinity PDBu receptors, believed to be 
cytoplasmic PKC, to high-affinity receptors 
representing PKC bound to plasma membrane 
phospholipid [3,5]. Nonetheless other indirect ef- 
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Fig.5. Scatchard plot of [3H]PDBu binding to PMN with or without pretreatment with A23187. 10 min pretreatment 
with 1 PM A23187 increased the affinity of binding of phorbol ester receptors from a single class of low affinity (& 
27 nM) to a single class of high affinity (& 10 nM). (m) PDBu alone; (0) PDBu + 1 yM A23187. Data represent one 
typical result from 3 experiments. Each point represents the mean of triplicates, SE did not exceed 2 fmol. 
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fects of Ca2+ on PDBu receptors cannot be ex- 
cluded. 
The action of A23187 on binding of PDBu 
(10 nM) was dose-dependent with a mean ( f SE) 
EC50 of 0.24 f 0.08 FM A23187 (n = 3), which 
correlated closely with the EC50 (0.18 + 0.07 pM) 
for the effect of A23187 on PDBu-induced 
superoxide release. The effect of A23 187 on PDBu 
binding was inhibited by EGTA or TMB-8 (table 
1). 
In conclusion these data provide further 
evidence that the basis for the synergistic effect of 
A23187 on the initial response of PMN to phorbol 
ester is due to a Ca2+-dependent increase in 
binding affinity of receptors for PDBu. In view of 
the lack of effect of A23187 on the response to 
maximal doses of PDBu, these data suggest hat 
A23 187 affects early events during PMN activation 
and are consistent with the recently proposed 
hypothesis that Ca2+ promotes translocation and 
binding of cytosolic PKC to the plasma membrane 
13951. 
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